Ms Tracey Conroy:

The review is an independent clinical review. RCOG will review all of the diagnoses of cervical cancer since the programme was established in 2008, including the 1,482 cases that were notified to CervicalCheck since then and the further 1,630 registered by the National Cancer Registry which had not been notified to CervicalCheck. The review will examine the women within this cohort who were screened by the programme, which is approximately 1,856 women from within the total but that is subject to final validation within the review. The review will examine the cases of women who developed cancer and were screened by CervicalCheck. All of their screening histories will be examined. This involves reviewing all of the smears. The panel will have an algorithm for examining the smears and it will identify the number of cases in which there are discordant results. A report in each case will be provided to the women involved. The panel has its own quality assurance system and it wants to work systematically so that it can stand over this process. We have been engaging with RCOG on a daily basis since it agreed to come on board with this review.